Skip to main content
Fig. 5 | Molecular Cancer

Fig. 5

From: Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition

Fig. 5

Functional profile of (Receptor) Tyrosine Kinases and their ligands across different cell types in the tumor microenvironment. Red shading indicates a cell type where a functional role of a given kinase or its ligand relevant to ICI efficacy has been demonstrated, for example by gene knock-out or pharmacological inhibition. Note that this may not indicate the expression profile per se, but where expression in a particular cell type has been linked to immunosuppression in the TME and the kinase/ligand represents a potential target for combination therapy with ICI. For details on each cell type please refer to text

Back to article page